CONTEXT: Very interesting peer reviewed paper looking at RWD in randomised trials | A huge amount of information to get your teeth into here, but the conclusions suggest RCT fans Continue Reading
CONTEXT: Commercial announcement of an updated RWE platform for collection of prospective study data along with external data sources from another leading RWE company (It must be getting crowded up Continue Reading
CONTEXT: Commercial announcement of another player in the RWE dataset market | The competition for people’s data is hotting up and you can get a sense for how valuable the Continue Reading
CONTEXT: Peer reviewed article | RWR uncovering potential diagnostic bias in NASH diagnoses again illustrates the power of large data sets in real-world settings to help physicians target the best Continue Reading
CONTEXT: Peer reviewed article on RWE in multiple myeloma | Pre-publication preview IMPACT: Medium READ TIME: 1 min Quality Level Mean [1 – 10]: 4 1. “We evaluated clinical outcomes among Continue Reading
CONTEXT: An opinion piece on the value of data sets in biomedical and neuroimaging studies, but only where they are compatible | When we still don’t have a common charger for Continue Reading
CONTEXT: A claim that will no doubt be tested – “Regulatory-grade evidence”. What exactly constitutes regulatory-grade RWE? Time will tell as we move into a new era for RWR | Continue Reading
CONTEXT: A study title that may slip through unnoticed as it does not explicitly mention RWR, but an interesting study showing how RWE can inform physicians on the impact of Continue Reading
FULL TITLE: Meeting the Urgent Needs of People Living with Dementia Requires Addressing Existing Disparities in Care, and Ensuring Future Research Prioritizes Inclusivity and Real-World Studies – National Academies of Continue Reading
CONTEXT: A proper peer reviewed study article on a retrospective study based on an oncology registry in Canada highlighting the differences in outcomes for rural versus urban patients. READ TIME: Continue Reading
